Miami ,
-
FDA Proposes Withdrawing Tavneos: Should Patients Stop Taking It?
The FDA has proposed withdrawing Tavneos, but it has not ordered an immediate recall. For patients with ANCA-associated vasculitis, the key step right now is to contact the prescribing specialist before stopping, switching, or delaying treatment.
-
Aurora Bay Area Prices – MAMMOGRAM DX BILATERAL is $540
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002476, regarding MAMMOGRAM DX BILATERAL, which is classified under revenue code 401 and associated with CPT code 77066, the designated fee stands at $540. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
New PSA Review Finds Modest Benefit, but Not Routine Screening
A May 2026 Cochrane review found that PSA screening likely prevents a small number of prostate-cancer deaths, but current U.S. guidance still favors shared decision-making for men 55 to 69 rather than routine testing for everyone.
-
Oral cancer screening is still worth asking about, even if you feel fine
A routine dental visit can include a quick mouth, head, and neck exam that may spot trouble early. But U.S. agencies do not recommend a universal stand-alone screening test for every symptom-free adult, because evidence is still insufficient. Here’s how to think about the exam, who should pay closer attention, and what to ask at your next visit.
